Belite Bio Inc

NASDAQ: BLTE · Real-Time Price · USD
65.16
-1.47 (-2.21%)
At close: Aug 18, 2025, 3:59 PM
64.95
-0.32%
After-hours: Aug 18, 2025, 04:42 PM EDT

Belite Bio Inc Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
449K 399K 198K 30K
Gross Profit
-449K -399K -198K -30K
Operating Income
-40M -31.67M -12.82M -9.8M
Interest Income
3.74M 74K 23K 5K
Pretax Income
-36.14M -31.62M -12.65M -9.67M
Net Income
-36.14M -31.63M -12.65M -9.67M
Selling & General & Admin
10.06M 6.82M 3.95M 2.38M
Research & Development
29.94M 24.84M 8.87M 7.42M
Other Expenses
-449K -399K n/a n/a
Operating Expenses
39.55M 31.27M 12.82M 9.8M
Interest Expense
20K 25K 16K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-40M 31.67M 12.82M 9.8M
Income Tax Expense
6K 9K n/a n/a
Shares Outstanding (Basic)
30.54M 26.59M 19.98M 24.1M
Shares Outstanding (Diluted)
30.54M 26.59M 19.98M 24.1M
EPS (Basic)
-1.18 -1.19 -0.63 -0.4
EPS (Diluted)
-1.18 -1.19 -0.63 -0.4
EBITDA
-35.67M -31.53M -12.43M -9.64M
EBIT
-36.12M -31.67M -12.63M -9.67M
Depreciation & Amortization
449K 139K 198K 30K